Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, No. 1838, North Guangzhou Avenue, Guangzhou, 510515, People's Republic of China.
Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Dig Dis Sci. 2020 Nov;65(11):3211-3222. doi: 10.1007/s10620-020-06052-5. Epub 2020 Jan 23.
Acute pancreatitis (AP) is a severe pancreatic disorder that remains associated with high mortality due to a lack of effective drugs and management strategies. This study aimed to investigate the molecular pathogenic mechanisms of AP involving p53 and endoplasmic reticulum (ER) stress pathways.
Expression of PRSS1 and p53 in human AP tissues was detected by immunohistochemistry and Western blotting. AP was induced with caerulein in humanized PRSS1 transgenic mice, and its severity was verified by histological imaging, evaluation of edema, serum amylase, and trypsin activity assays. A transferase-mediated d-UTP nick end-labeling assay was performed to evaluate acinar cell apoptosis associated with AP. The expression of ER stress genes was assessed by quantitative RT-PCR (qRT-PCR) and Western blotting.
PRSS1 and p53 were highly expressed in human AP tissues. Expression of human PRSS1 in caerulein-treated mice induced significant acinar cell apoptosis and AP progression. P53 knockout significantly suppressed AP progression in humanized PRSS1 transgenic mice. The ER stress pathway was activated by PRSS1 and mediated the progression of AP in mouse pancreatic tissues. Application of a p53 inhibitor effectively ameliorated caerulein-induced AP in PRSS1 transgenic mice, while a p53 activator promoted the progression of AP.
P53, which was activated by the ER stress pathway, promoted the progression of AP in mice expressing PRSS1 by inducing acinar cell apoptosis.
急性胰腺炎(AP)是一种严重的胰腺疾病,由于缺乏有效的药物和治疗策略,其死亡率仍然很高。本研究旨在探讨涉及 p53 和内质网(ER)应激途径的 AP 的分子发病机制。
通过免疫组织化学和 Western blot 检测人 AP 组织中 PRSS1 和 p53 的表达。用人源化 PRSS1 转基因小鼠用 caerulein 诱导 AP,并通过组织学成像、水肿评估、血清淀粉酶和胰蛋白酶活性测定来验证其严重程度。通过转移酶介导的 d-UTP 缺口末端标记法评估与 AP 相关的腺泡细胞凋亡。通过定量 RT-PCR(qRT-PCR)和 Western blot 评估 ER 应激基因的表达。
PRSS1 和 p53 在人 AP 组织中高表达。在 caerulein 处理的小鼠中表达人 PRSS1 诱导明显的腺泡细胞凋亡和 AP 进展。p53 敲除显著抑制人源化 PRSS1 转基因小鼠中的 AP 进展。PRSS1 激活 ER 应激途径,介导小鼠胰腺组织中 AP 的进展。p53 抑制剂的应用可有效改善 PRSS1 转基因小鼠中 caerulein 诱导的 AP,而 p53 激活剂则促进 AP 的进展。
通过诱导腺泡细胞凋亡,被 ER 应激途径激活的 p53 促进了表达 PRSS1 的小鼠中 AP 的进展。